Atlas Trials

Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis

Clinical trial NCT03061721 · COMPLETED

Trial details

NCT number
NCT03061721
Sponsor
Zydus Therapeutics Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Start date
2017-04-06
Primary completion
2019-08-22
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.